The effect of cranial osteopathy on optic nerve sheath diameter in healthy volunteers: randomized crossover clinical trial.

ANGEL BURREL BOTAYA0 个研究点目标入组 28 人开始时间: 2022年5月12日最近更新: 2022年9月5日

适应症

试验速览

暂无简介。

•Any disease that affects the intracranial pressure (ICP), the optic nerve or the intraocular pressure. Such as head trauma, stroke, tumors, glaucoma, diabetes, diagnosis of neurological disease, history of metabolic disease, history of cardiovascular, rheumatic, oncological disease, taking medication that affects cerebrospinal fluid (CSF) or intraocular pressure (IOP), history of increased ICP or IOP, history of dizziness, headache or vertigo in the last 4 weeks. Severe orthostatic intolerance. Taking any medication. Diopters of more than +5 or less than -6. Vulnerable population such as pregnant women, lactating women or people unable to give their consent will also be excluded.
•Exclusion criteria will be if the blood pressure measurements show a diastolic pressure greater than 90 mmHg, or less than 50 mmHg; and a systolic greater than 150mmHg, or less than 100mmHg; or a heart rate greater than 100 beats/min, or less than 50 beats/min. as well as an initial optic nerve diameter greater than 6 mm.

发起方

ANGEL BURREL BOTAYA